TITLE

Asthma research claims life of test participant

AUTHOR(S)
Sibbald, Barbara
PUB. DATE
August 2001
SOURCE
CMAJ: Canadian Medical Association Journal;8/21/2001, Vol. 165 Issue 4, p464
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the death of Ellen Roche, a participant in a clinical trial at the Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Description of her death; Question that her death raises about how adequately medical research participants are informed and protected; Details of the investigation of the trial; Concerns about patient safety.
ACCESSION #
5047241

 

Related Articles

  • Trials and errors: A hospital takes a hit. Schultz, Stacey // U.S. News & World Report;7/30/2001, Vol. 131 Issue 4, p19 

    Reports that human research was halted at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. How Ellen Roche died after taking a dose of the asthma medication, hexamethonium, which researchers had failed to tell her carried medical risks; Safety problems found at Johns Hopkins by...

  • Second US institute investigates use of drug in asthma trial. Josefson, Deborah // BMJ: British Medical Journal (International Edition);8/11/2001, Vol. 323 Issue 7308, p299 

    Focuses on the death of volunteer Ellen Roche from complications in an asthma study at Johns Hopkins University in Baltimore, Maryland. Use of inhaled hexamethonium to induce bronchoconstriction and simulate asthma; How principal investigator Dr. Alkis Togias relied on an earlier study at the...

  • Dying for Science. Begley, Sharon; Foote, Donna; Rogers, Adam // Newsweek (Atlantic Edition);7/30/2001 (Atlantic Edition), Vol. 138 Issue 5, p32 

    Reports on the impact of the death of Ellen Roche during a medical experiment at Johns Hopkins University. Finding by the Office for Human Research Protections that the university has poor safeguards for human subjects; Details of the case.

  • Dying for Science. Begley, Sharon; Foote, Donna; Rogers, Adam // Newsweek (Pacific Edition);7/30/2001 (Pacific Edition), Vol. 138 Issue 5, p28 

    Reports on the impact of the death of Ellen Roche during a medical experiment at Johns Hopkins University. Finding by the Office for Human Research Protections that the university has poor safeguards for human subjects; Details of the case.

  • Dying for Science. Begley, Sharon; Foote, Donna; Rogers, Adam // Newsweek;7/30/2001, Vol. 138 Issue 5, p36 

    Reports on the impact of the death of Ellen Roche during a medical experiment at John Hopkins University. Finding by the Office for Human Research Protections that the university has poor safeguards for human subjects; Details of the case.

  • Retracing events.  // Nature Biotechnology;Sep2007, Vol. 25 Issue 9, p949 

    The author reflects on the link between adeno-associated virus (AAV) gene therapy and the patient's death treated with it in the U.S. He denotes that the two deaths in seven years connected to gene therapy should not be the reason for a regulatory crackdown. He asserts that further research on...

  • A promising experiment ends in tragedy. Roberts, Leslie // U.S. News & World Report;10/11/99, Vol. 127 Issue 14, p43 

    Offers information on the death of Jesse Gelsinger, a participant in a gene-therapy study at the University of Pennsylvania. History of his suffering from ornithene transcarbamylase deficiency (OTC); Goal of the clinical trial to deliver a normal version of a defective gene; Investigation...

  • Modifying Clinical Trial Designs to Test Treatments for Clinical Significance in Individual Patients. Becker, R.E. // Clinical Drug Investigation;2001, Vol. 21 Issue 10, p727 

    The aim of this article was to design clinical trials that test treatments for clinical significance in individual patients. In a repeated measures design a scalar summary statistic describes the clinical course of each individual. To provide satisfactory reliability for each patient's clinical...

  • Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. Avins, Andrew L // Journal of Medical Ethics;Dec98, Vol. 24 Issue 6, p401 

    Examines several techniques for addressing the issue of randomised clinical trials. Suggestion that unbalanced randomisation may be useful for enhancing the ethical design of human experimentation; Approach to the dilemma of equipoise and randomised trials; Methodologic approaches to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics